Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Yifeng Pharmacy(603939) the Revenue is 6.045 B (+5.82%), Miss estimate;the EBIT is 718.98 M (+15.63%), Beat estimate;the EPS is 0.38 (+8.57%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
6.04B5.82%
6.45B12.98%
-0.41B7.16%
EBITExceed expectations
0.72B15.63%
0.68B8.65%
+0.04B6.98%
EPSMiss expectations
0.388.57%
0.398413.83%
-0.01845.26%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf